LakeShore Biopharma Co. L... (LSB)
NASDAQ: LSB
· Real-Time Price · USD
0.79
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
0.79
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
LakeShore Biopharma Ltd Income Statement
Financials in CNY. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | 577.33M | 547.92M | 559.67M | 657.64M | 481.37M | 375.25M | 194.79M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 188.21M | 108.24M | 111.62M | 136.83M | 102.15M | 81M | 42.73M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 389.12M | 439.68M | 448.06M | 520.81M | 379.21M | 294.25M | 152.06M | n/a | n/a | n/a | n/a | n/a |
Operating Income | -448.56M | -340.91M | -304.55M | -197.27M | -129.96M | -57.95M | -12.08M | -7.47M | -4.98M | -3.49M | -1.57M | -260.75K |
Interest Income | 1.99M | 1.99M | 8.71M | 14.35M | 16.16M | 16.29M | 9.57M | 1.98M | 174.52K | 46.58K | 19.68K | 3.08K |
Pretax Income | -457.84M | -374.61M | -374.57M | -298.65M | -217M | -60.06M | 47.23M | 83.21M | 41.44M | -3.83M | -23.56M | -30.24M |
Net Income | -436.09M | -365.75M | -338.33M | -224.85M | -143.79M | 12.56M | 85.03M | 83.21M | 41.44M | -3.83M | -23.56M | -30.24M |
Selling & General & Admin | 437.63M | 421.29M | 367.44M | 354.13M | 245.87M | 201.1M | 107.15M | 7.47M | 4.98M | 3.49M | 1.57M | 260.74K |
Research & Development | 305.91M | 344.09M | 373.15M | 348.71M | 248.07M | 151.07M | 53.77M | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 93.55M | 14.61M | 14.61M | 14.99M | 15.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 823.05M | 765.96M | 770.99M | 765.39M | 557.97M | 400.99M | 179.92M | 7.47M | 4.98M | 3.49M | 1.57M | 260.74K |
Interest Expense | 46.91M | 23.28M | 14.93M | 62.12M | 103.51M | 103.51M | 103.51M | 49.42M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 301.12M | 277.55M | 279.96M | 281.49M | 202.3M | 153.79M | 80.03M | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.01B | 874.2M | 882.61M | 902.22M | 660.12M | 481.99M | 222.64M | 7.47M | 4.98M | 3.49M | 1.57M | 260.74K |
Income Tax Expense | -21.99M | -7.67M | 935.48K | 1.22M | 1.8M | 1.2M | 46.55K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 99.99M | 93.06M | 93.06M | 93.06M | 85.24M | 61.79M | 61.74M | 25.75M | 25.75M | 29.5M | 29.5M | 28.75M |
Shares Outstanding (Diluted) | 99.99M | 93.06M | 93.06M | 93.06M | 85.24M | 61.79M | 61.74M | 25.75M | 25.75M | 29.5M | 29.5M | 28.75M |
EPS (Basic) | -4.54 | -4.03 | -4 | -2.73 | -1.54 | 1.54 | 3.07 | 3.15 | 1.68 | -0.1 | -0.8 | -1.03 |
EPS (Diluted) | -4.54 | -4.03 | -4 | -2.73 | -1.54 | 1.54 | 3.07 | 3.15 | 1.68 | -0.1 | -0.8 | -1.03 |
EBITDA | -315.55M | -288.58M | -256.29M | -43.58M | 15.77M | 69.94M | 108.07M | -7.47M | -4.98M | -3.49M | -1.57M | -260.75K |
EBIT | -265.09M | -181.35M | -176.82M | -72.8M | -22.31M | -17.83M | -7.75M | -12.42M | -5.5M | -542.09K | -3.64M | -4.68M |
Depreciation & Amortization | 35.69M | 34.33M | 32.91M | 26.83M | 25.56M | 16.38M | 8.65M | n/a | n/a | n/a | n/a | n/a |